Study of Clinical & Molecular Manifestations of Genetic Disorders

Status Completed

Clinical Trial Summary

This study will investigate the cause and natural history (medical problems that appear over time) of certain genetic disorders. It will also try to locate the abnormal genes responsible for these conditions and eventually develop tests to predict who is likely to be affected and to what degree.

Patients with known or suspected genetic disorders in certain categories, such as those involving chromosomal or metabolic abnormalities, immune system or blood disorders, abnormal growth, benign tumors, and others may be eligible for this study. Participants will be interviewed by specialists in genetics about their condition and family history. They may also be asked to have a physical examination and certain tests needed for study of the specific individual's condition. These may include collection of blood samples (up to 3 tablespoons); imaging studies, such as computerized tomography (CT), magnetic resonance imaging (MRI), ultrasound and echocardiography; skin biopsy (removal of a small sample of skin tissue under local anesthetic), and other procedures. DNA testing may reveal the genetic abnormality responsible for the disorder. Participants who so wish will have an opportunity to talk with experts about the health implications of the test results.

This study may provide information that will lead to improved treatment or management of these inherited disorders, as well as more effective genetic counseling for families.

Clinical Trial Description

Individuals and their families affected by disorders with a potentially genetic basis within six broad categories will be evaluated over time to characterize the natural and clinical history of various specific disorders. Medical and laboratory evaluations will be completed to identify areas of management concern that have not been previously described. Further protocols will be developed addressing specific disorders once a number of affected individuals have been investigated and is sufficient to query various aspects of those disorders. Issues for both diagnosis and medical management of those affected with certain genetic disorders will be collated and addressed within a national consensus conference format. In addition, phenotype to genotype correlation will be established to further understanding of specific molecular alterations on phenotypic expression. This broad-based protocol will also facilitate the training of fellows in medical genetics, graduate and post graduate training in genetics and genetic counseling. ;

Study Design

N/A

Related Conditions & MeSH terms

Hereditary Diseases

Clinical Trial Details

NCT number	NCT00001466
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Completed
Phase	N/A
Start date	October 1994
Completion date	October 2000

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05358964` - Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community	N/A
Recruiting	`NCT06183138` - Multicenter Analysis of Genomic and Metabolic Data of Neonatal Genetic Diseases
Recruiting	`NCT06107400` - Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease	Early Phase 1
Active, not recruiting	`NCT04428710` - Assessment Psychological Distress for Cancer Heredity Test
Recruiting	`NCT04531696` - UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research	N/A
Completed	`NCT01343953` - Cord Blood Transplantation in Severe Aplastic Anemia	Phase 2
Enrolling by invitation	`NCT05721326` - Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition	N/A
Enrolling by invitation	`NCT04548921` - Biomarker for Friedreich's Ataxia (BioFridA)
Recruiting	`NCT06330441` - Pancreatic Cancer Screening in a Population at High Risk	N/A
Completed	`NCT02416440` - Durban Diabetes Study:A Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent (DDS)	Phase 0
Recruiting	`NCT05587439` - Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Withdrawn	`NCT04531878` - BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases	Phase 2/Phase 3
Completed	`NCT02917070` - Parental Consanguinity and Family History of Kidney Disease in Turkish Kidney Disease Population	N/A
Active, not recruiting	`NCT01645904` - A Social Media Approach to Improve Genetic Risk Communication Phase I
Recruiting	`NCT05161169` - Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants	N/A
Recruiting	`NCT06157983` - Evaluation of Cascade Screening for Elevated Lipoprotein(a)
Active, not recruiting	`NCT04528498` - Embryo Health Study
Completed	`NCT05453474` - Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling	N/A
Terminated	`NCT00314691` - Development of New Prenatal Diagnostic Tests From Maternal Blood	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study of Clinical and Molecular Manifestations of Genetic Disorders

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms